Taiwan FDA registration 574a35213772b94d0445df993ee0604e

"Haifeng Biomedical" Edoxaban quality control liquid group

TW: “海奉生物醫學” Edoxaban品管液組

Taiwan·Risk Class 2·HYPHEN BioMed·Registered May 20, 2021 – May 20, 2026Expired

Registration details

Analysis ID: 574a35213772b94d0445df993ee0604e
Customs Code: DHA05603465705

Company information

Manufacturer: HYPHEN BioMed
Manufacturer Country: France
Authorized Representative: SYSMEX TAIWAN CO., LTD.

Product details

Intended Use: This product is lyophilized human plasma mixed with different concentrations of Edoxaban for quality control of Edoxaban measurement.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1660 Quality control materials (analytical and non-analytical)
Import Information: QMS/QSD;; 輸入

Dates and status

Registration Date: May 20, 2021
Expiry Date: May 20, 2026

About this record

Access comprehensive regulatory information for "Haifeng Biomedical" Edoxaban quality control liquid group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 574a35213772b94d0445df993ee0604e and manufactured by HYPHEN BioMed. The authorized representative in Taiwan is SYSMEX TAIWAN CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.